These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30034338)

  • 21. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Master Transcriptional Regulators in Cancer: Discovery via Reverse Engineering Approaches and Subsequent Validation.
    Moran B; Rahman A; Palonen K; Lanigan FT; Gallagher WM
    Cancer Res; 2017 May; 77(9):2186-2190. PubMed ID: 28428271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Web-based drug repurposing tools: a survey.
    Sam E; Athri P
    Brief Bioinform; 2019 Jan; 20(1):299-316. PubMed ID: 29028878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico drug repositioning: what we need to know.
    Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
    Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An update on Drug Repurposing: Re-written saga of the drug's fate.
    Gns HS; Gr S; Murahari M; Krishnamurthy M
    Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.
    Issa NT; Kruger J; Wathieu H; Raja R; Byers SW; Dakshanamurthy S
    BMC Bioinformatics; 2016 May; 17(1):202. PubMed ID: 27151405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug repositioning for dengue haemorrhagic fever by integrating multiple omics analyses.
    Amemiya T; Gromiha MM; Horimoto K; Fukui K
    Sci Rep; 2019 Jan; 9(1):523. PubMed ID: 30679503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. gene2drug: a computational tool for pathway-based rational drug repositioning.
    Napolitano F; Carrella D; Mandriani B; Pisonero-Vaquero S; Sirci F; Medina DL; Brunetti-Pierri N; di Bernardo D
    Bioinformatics; 2018 May; 34(9):1498-1505. PubMed ID: 29236977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns.
    Salentin S; Adasme MF; Heinrich JC; Haupt VJ; Daminelli S; Zhang Y; Schroeder M
    Sci Rep; 2017 Sep; 7(1):11401. PubMed ID: 28900272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug repositioning for diabetes based on 'omics' data mining.
    Zhang M; Luo H; Xi Z; Rogaeva E
    PLoS One; 2015; 10(5):e0126082. PubMed ID: 25946000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug Repositioning for Schizophrenia and Depression/Anxiety Disorders: A Machine Learning Approach Leveraging Expression Data.
    Zhao K; So HC
    IEEE J Biomed Health Inform; 2019 May; 23(3):1304-1315. PubMed ID: 30010603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MD-Miner: a network-based approach for personalized drug repositioning.
    Wu H; Miller E; Wijegunawardana D; Regan K; Payne PRO; Li F
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):86. PubMed ID: 28984195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating transcriptional and protein interaction networks to prioritize condition-specific master regulators.
    Padi M; Quackenbush J
    BMC Syst Biol; 2015 Nov; 9():80. PubMed ID: 26576632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Network mirroring for drug repositioning.
    Park S; Lee DG; Shin H
    BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):55. PubMed ID: 28539121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug repositioning based on the target microRNAs using bilateral-inductive matrix completion.
    Deepthi K; Jereesh AS
    Mol Genet Genomics; 2020 Sep; 295(5):1305-1314. PubMed ID: 32583015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro screening for drug repositioning.
    Wilkinson GF; Pritchard K
    J Biomol Screen; 2015 Feb; 20(2):167-79. PubMed ID: 25527136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Turning genome-wide association study findings into opportunities for drug repositioning.
    Lau A; So HC
    Comput Struct Biotechnol J; 2020; 18():1639-1650. PubMed ID: 32670504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry.
    So HC; Chau CK; Chiu WT; Ho KS; Lo CP; Yim SH; Sham PC
    Nat Neurosci; 2017 Oct; 20(10):1342-1349. PubMed ID: 28805813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.
    Nagaraj AB; Wang QQ; Joseph P; Zheng C; Chen Y; Kovalenko O; Singh S; Armstrong A; Resnick K; Zanotti K; Waggoner S; Xu R; DiFeo A
    Oncogene; 2018 Jan; 37(3):403-414. PubMed ID: 28967908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting targeted polypharmacology for drug repositioning and multi- target drug discovery.
    Liu X; Zhu F; Ma XH; Shi Z; Yang SY; Wei YQ; Chen YZ
    Curr Med Chem; 2013; 20(13):1646-61. PubMed ID: 23410165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.